Doribax - 2007 FDA approvals

Drug: Doribax (doripenem)
Indication: Urrinary tract infections
Company: Johnson & Johnson
Approval Date: October 12, 2007

Scoop: DORIBAX belongs to a class of antibacterial agents called carbapenems, which are important for treating serious infections caused by Gram-positive and Gram-negative bacteria. The drug is approved for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.

Doribax - 2007 FDA approvals
Read more on

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i